Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
Titel:
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
Auteur:
Tovoli, Francesco Pallotta, Dante Pio Vivaldi, Caterina Campani, Claudia Federico, Piera Palloni, Andrea Dalbeni, Andrea Soldà , Caterina Lani, Lorenzo Svegliati-Baroni, Gianluca Garajova, Ingrid Ielasi, Luca De Lorenzo, Stefania Granito, Alessandro Stefanini, Bernardo Masi, Gianluca Marra, Fabio Lonardi, Sara Brandi, Giovanni Daniele, Bruno Auriemma, Alessandra Schiadà , Laura Chen, Rusi Piscaglia, Fabio